Article
Early human B cell signatures of the primary antibody response to mRNA vaccination
27 Jun 2022
Abstract excerpt
Messenger RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly effective at inducing protective immunity. However, weak antibody responses are seen in some individuals, and cellular correlates of immunity remain poorly defined, especially for B cells. Here we used unbiased approaches to longitudinally dissect primary antibody, plasmablast, and memory B cell (MBC)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
